EP2106259A2 - USE OF COMPOSITIONS COMPRISING AT LEAST ONE ALFA3 BETA4 NACHR ANTAGONIST SUCH AS MECAMYLAMINE IN THE TREATMENT OF GASTROINTESTINAL DISORDERS